Versameb

Versameb AG is a preclinical-stage biopharmaceutical company located in Basel, Switzerland, managed by an experienced team of scientific and commercial pharmaceutical industry professionals. The company focuses on developing novel RNA-based therapies. Versameb's proprietary VERSagile technology platform enables the efficient development of functional mRNA molecules for customized protein expression and modification across multiple disease areas with unmet medical needs.